ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) announced participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022. Chief Financial Officer Zach Stassen and VP of Clinical Affairs Paul Strong will host a virtual fireside chat at 3:00 p.m. Eastern Time. The conference is exclusive to BTIG clients, and interested parties should contact their BTIG representative to attend. ViewRay designs and markets the MRIdian MR-Guided Radiation Therapy System, addressing unique challenges in advanced radiation oncology.

CLEVELAND, Feb. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Zach Stassen, Chief Financial Officer, and Paul Strong VP, Clinical Affairs, will participate in a virtual fireside chat at 3:00 p.m. Eastern Time on Thursday, February 17, 2022. BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.

About ViewRay®
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:https://www.prnewswire.com/news-releases/viewray-to-participate-in-the-btig-medtech-digital-health-life-science--diagnostic-tools-conference-301479502.html

SOURCE ViewRay, Inc.

FAQ

When is ViewRay participating in the BTIG MedTech Conference?

ViewRay will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022.

Who from ViewRay will speak at the conference?

Zach Stassen, Chief Financial Officer, and Paul Strong, VP of Clinical Affairs, will participate.

What time is the ViewRay virtual fireside chat?

The virtual fireside chat will take place at 3:00 p.m. Eastern Time.

How can I listen to ViewRay's presentation at the conference?

To listen to the live event, interested individuals should contact their BTIG representative.

What is the MRIdian system developed by ViewRay?

MRIdian is an MR-Guided Radiation Therapy System designed to address challenges in radiation oncology.